- Home
- FBLG
FBLG
FIBROBIOLOGICS INC
as 06-03-2025 11:36am EST
Stocks
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | HOUSTON |
| Market Cap: | 37.1M | IPO Year: | 2024 |
| Target Price: | $13.00 | AVG Volume (30 days): | 191.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.22 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.70 - $13.44 | Next Earning Date: | 05-14-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of FIBROBIOLOGICS INC (FBLG)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Khoja Hamid | FBLG | Chief Scientific Officer | May 27 '25 | Buy | $0.84 | 20,000 | $16,800.00 | 31,250 |
Latest FIBROBIOLOGICS INC News
FBLG Breaking Stock News: Dive into FBLG Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
12 days ago
FBLG: Poster Presentation Shows Potential for Fibroblast Therapy in Psoriasis…
GlobeNewswire
18 days ago
FibroBiologics Presents at the Society for Investigative Dermatology Annual Meeting
GlobeNewswire
20 days ago
FibroBiologics Reports First Quarter 2025 Financial Results and Provides Corporate Update
GlobeNewswire
a month ago
FibroBiologics Presents at the ThymUS 2025 Meeting
GlobeNewswire
a month ago
FibroBiologics Presenting at the ThymUS 2025 Meeting
GlobeNewswire
2 months ago
FibroBiologics to Present at The Cell & Gene Meeting on the Mediterranean
Zacks Small Cap Research
2 months ago
OTC Markets Hosts Virtual Investor Presentation with Pete O'Heeron, CEO & Chairman of FibroBiologics, Inc., with David Bautz, PhD, Senior Analyst at Zacks SCR
GlobeNewswire
2 months ago
FibroBiologics Unveils New and Expanded Houston Laboratory Space to Pursue Innovation and Breakthroughs in Fibroblast-Based Therapeutics
Compare FBLG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FBLG FIBROBIOLOGICS INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.